4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study (Q42460350)

1 November 2017

title

4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study (English)

1 reference

coronary artery bypass surgery

1 November 2017

0 references

1 reference

2

1 reference

1 November 2017

Francesco Burzotta

1

0 references

Maria Benedetta Donati

object named as

Maria Benedetta Donati

8

0 references

Gianfederico Possati

10

object named as

GianFederico Possati

1 reference

1 November 2017

Augusto Di Castelnuovo

3

object named as

Augusto Di Castelnuovo

1 reference

1 November 2017

6

Concetta Amore

1 reference

1 November 2017

7

Rocco Schiavello

1 reference

1 November 2017

11

Felicita Andreotti

1 reference

1 November 2017

Roberto Zamparelli

4

1 reference

1 November 2017

Andria D'Orazio

5

1 reference

1 November 2017

Attilio Maseri

9

1 reference

1 November 2017

publication date

1 December 2003

1 reference

Journal of Thrombosis and Thrombolysis

1 November 2017

published in

1 reference

1 November 2017

volume

16

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

149-154

1 reference

The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis

1 November 2017

cites work

1 reference

12 December 2020

Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis

1 reference

12 December 2020

Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism

1 reference

12 December 2020

Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation

1 reference

12 December 2020

Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.

1 reference

12 December 2020

The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctu

1 reference

12 December 2020

4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction

1 reference

12 December 2020

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

1 reference

12 December 2020

Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients

1 reference

12 December 2020

One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin

1 reference

12 December 2020

Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

1 reference

12 December 2020

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

12 December 2020

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

12 December 2020

Normothermia does not improve postoperative hemostasis nor does it reduce inflammatory activation in patients undergoing primary isolated coronary artery bypass.

1 reference

12 December 2020

Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor

1 reference

12 December 2020

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

1 reference

12 December 2020

Individual variations in the fibrinolytic response during and after cardiopulmonary bypass.

1 reference

12 December 2020

Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke

1 reference

12 December 2020

Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.

1 reference

12 December 2020

Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

1 reference

12 December 2020

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

12 December 2020

10.1023/B:THRO.0000024052.79415.62

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1006736460

0 references

1 reference